Literature DB >> 11482121

Cost of smoking to the Medicare program, 1993.

X Zhang1, L Miller, W Max, D P Rice.   

Abstract

Medicare expenditures attributable to smoking in 1993 were estimated using a multivariate model that related expenditures to smoking history, health status, and the propensity to have had a smoking-related disease, controlling for sociodemographics, economic variables, and other risk factors. Smoking-attributable Medicare expenditures are presented separately for each State and by type of expenditure. Nationally, smoking accounted for 9.4 percent of Medicare expenditures--$14.2 billion, with considerable variation among States. Smoking accounted for 11.4 percent of Medicare expenditures for hospital care, 11.3 percent of nursing home care, 5.9 percent of home health care, and 5.6 percent of ambulatory care.

Entities:  

Mesh:

Year:  1999        PMID: 11482121      PMCID: PMC4194599     

Source DB:  PubMed          Journal:  Health Care Financ Rev        ISSN: 0195-8631


Introduction

Interest in the costs related to smoking has never been higher. Previous research has looked at the cost borne by taxpayers to treat people with smoking-related diseases under Medicaid. For the first time, we use these methods to look at the costs to Medicare, which covers the medical expenses of 34 million Americans age 65 or over and 5.5 million persons with disabilities. The numbers are significant: 16 percent of Medicare enrollees in 1994 reported themselves as current smokers, and another 44 percent reported themselves as former smokers (Olin and Liu, 1998). The published literature during the past three decades abounds with estimates of the annual costs of smoking in the United States (Hedrick, 1971; Luce and Schweitzer, 1978; Kristein, 1977; Rice et al., 1986; Office of Technology Assessment, 1985 and 1993; Bartlett et al., 1994). Several studies include only the direct medical care costs; others include the indirect costs, the value of unpurchased resources lost attributable to smoking. These studies yield national cost estimates. Recently, two articles were published that presented State-level estimates of Medicaid smoking-attributable expenditures (SAEs) (Miller et al., 1998a) and total SAEs (Miller et al., 1998b). In this article, we present State estimates of Medicare expenditures attributable to smoking for the Medicare population, including those with disabilities. Estimates are reported by type of expenditure. Also presented are the Medicaid, residual public and private, and total SAEs for each State. Presentation of these State estimates enables each State to quantify its financial burden of smoking by source of payment.

Methods

The estimation of Medicare SAEs involved four steps: (1) a national model of Medicare SAEs was estimated; (2) the national model was applied to the States; (3) a national estimate was derived from the sum of the State estimates; and (4) interval estimates from the national model were applied to the State estimates.

National Model

We estimated the Medicare expenditure models with data from respondents who were age 65 or over in the National Medical Expenditure Survey (NMES) (Agency for Health Care Policy and Research, 1991). The model has three parts: a sample-bias correction equation; two morbidity equations estimating the effect of smoking history on smoking-related diseases and poor health status; and six expenditure equations estimating the effect of health status and smoking history on the likelihood of three different types of expenditures and on their positive magnitudes. Although there are separate models by sex, we shall refer to these models in the singular. We discuss these three parts in turn. A more detailed description of the national model and its estimation is contained in the Technical Note.

Sample Bias

There may be sample-selection bias introduced by the fact that the NMES obtained data on smoking history through its supplemental survey, which was conducted approximately 4½ months into its annual study. Not every NMES respondent completed the survey. For example, participants who died in the first quarter did not participate. Any bias in participating would reflect two countervailing tendencies. First, the likelihood that people who were more concerned about health issues, and hence were more likely to participate in the supplemental survey, were likely to have a higher demand for medical services. Second, participants who were sicker and needed more medical services were less likely to participate. Bias is likely to occur in the estimation of ambulatory care, which is more likely a function of demand (i.e., discretionary) than for hospital or home health care, where services are more determined by supply than demand.

Morbidity

The morbidity portion of the model estimates the effect of smoking history (current, never smokers, or former/unknown smoking status) on previous disease and the effect of smoking history and the propensity for previous disease on self-reported poor health status. The first morbidity equation explains the propensity of a NMES participant (in the supplemental survey) “… to have previously been told by a doctor” that he or she had any of five diseases (cancer, emphysema, heart conditions, arteriosclerosis, and stroke) that proxy for the broad class of smoking-related diseases discussed in the Surgeon General's Reports (Centers for Disease Control, 1989). The second equation estimates the propensity for poor health as a function of the propensity to have previously had a smoking-related disease. Health is self-reported as excellent, good, fair, or poor. There is a measurement error associated with the previous smoking-related disease measure and the self-reported health measure, because smoking is not known to be related to all cancers. For example, skin cancer, the most prevalent form of cancer, is not known to be influenced by smoking.

Expenditures

Two Medicare expenditure equations were estimated for each of three types of medical expenditures: ambulatory, hospital, and home health expenditures. For each type, the first equation is a probit equation estimating the propensity for positive Medicare expenditures. The second equation is a log expenditure equation estimating the logarithm of the magnitude of expenditures, given expenditures were positive. Each equation was specified as a function of a participant's expected propensity for self-reported poor health status, conditional on their reported poor health status, and smoking history, controlling for sociodemographics, economic variables, and other risk factors.

SAEs and Smoking Attributable Fractions

SAEs are the difference between predicted expenditures for smokers and predicted expenditures for a hypothetical group of non-smoking smokers, i.e., non-smokers who are similar to the smokers in every way except smoking status. The Medicare smoking-attributable fraction (SAF) is the ratio of smoking-attributable Medicare expenditures to total Medicare expenditures. The change in smoking status affects the expected propensity to have a smoking-related disease and expected health status, both of which in turn affect expected expenditures. Although health status and prior treatment are known for smokers, an adjustment was made to the SAFs to take into account the fact that these variables cannot be known for hypothetical non-smoking smokers. This adjustment is described in previous work (Miller et al., 1998a,b). Because the NMES did not include expenditures for nursing home care, SAEs for nursing home care were estimated by applying the SAFs for hospital expenditures for people age 65 or over to total nursing home expenditures, as in our previous studies about State Medicaid SAEs (Miller et al., 1998a) and State total SAEs (Miller et al., 1998b).

Estimation of State Medicare SAEs

Smoking-attributable Medicare expenditures for each State were estimated by substituting into the national model's equations values for people age 65 or over from each State. The individuals in each State's 1993 Behavioral Risk Factor Surveillance System (BRFSS) survey (Centers for Disease Control and Prevention, 1993) who were age 65 or over were used to represent the Medicare recipients in the State. Additionally, we assumed that BRFSS was a random sample and set the inverse Mill's terms in the morbidity and ambulatory expenditure equations to zero. The State SAFs were then calculated based on these expected expenditures. Because there were no 1993 BRFSS data for Wyoming, the SAFs for Wyoming are the means of the corresponding SAFs for its contiguous States: Colorado, Idaho, Montana, Nebraska, South Dakota, and Utah. The resulting State Medicare SAFs were applied to State total Medicare expenditures (Table 1), obtained from the Health Care Financing Administration (Levit et al., 1995). At the State level, Medicare expenditures are not available by age group. Although a small portion of Medicare expenditures are for disability payments for persons under age 65, we assumed that Medicare SAFs would not differ substantially by age. Therefore, we applied the SAF estimated for Medicare recipients age 65 or over to total Medicare expenditures for each State.
Table 1

Total Medicare Expenditures in Millions, by State and Type of Expenditure: United States, Calendar Year 1993

StateAll TypesAmbulatory Care1Hospital CareHome Health ServicesNursing Home
United States$150,373$43,812$94,228$8,022$4,311
Alabama2,6256761,61327264
Alaska101227621
Arizona2,2778071,2989478
Arkansas1,4223749626422
California17,3476,0269,895735691
Colorado1,5554181,0136361
Connecticut2,1345941,258167115
Delaware377113240168
District of Columbia603134445159
Florida12,4844,7636,438801482
Georgia3,5499352,18734879
Hawaii497173306126
Idaho384912571719
Illinois6,4041,7704,219284131
Indiana3,1267122,105147162
Iowa1,4473631,043338
Kansas1,3253748874321
Kentucky2,1446031,37611550
Louisiana2,7306651,74930313
Maine606150391587
Maryland2,6927791,7787956
Massachusetts4,7121,1023,017378215
Michigan5,4061,5733,449257127
Minnesota2,1635901,4305390
Mississippi1,36734883916614
Missouri3,4398602,39511371
Montana390952711311
Nebraska7461955271311
Nevada7322554114422
New Hampshire4731143093911
New Jersey4,8381,6962,94411880
New Mexico5651663542916
New York11,8733,3517,907375240
North Carolina3,5521,0012,25221089
North Dakota3759526956
Ohio6,1761,6774,066223210
Oklahoma1,6663961,10814616
Oregon1,5214699325070
Pennsylvania10,0552,8126,619353271
Rhode Island6651714254722
South Carolina1,54141797811036
South Dakota3649026428
Tennessee3,5488312,10752882
Texas8,7652,3685,558681158
Utah6251453995526
Vermont24251160283
Virginia2,7357621,81710155
Washington2,3607041,42597134
West Virginia1,1052977563715
Wisconsin2,3966051,60374114
Wyoming1493410195

Includes physician and other professional services and medical durables.

SOURCE: (Levit et al., 1995).

Interval Estimates

Interval estimates of Medicare SAEs were estimated by type of care for the Nation using a “jackknife” estimation (Rao, Wu, and Yue, 1992; Miller et al., 1998a), and the relative errors from this analysis were applied to each State's estimates.

Results

Estimated SAFs

Table 2 presents estimated Medicare SAFs for State expenditures by type of medical expenditure for calendar year 1993. Nationally, the SAF for all States and Washington, DC, was 9.43 percent. The highest SAF, 11.44 percent, was for hospital care. The lowest SAF (5.58 percent) was for ambulatory care services.
Table 2

Smoking-Attributable Fractions (SAFs) of Medicare Expenditures, by State and Type of Expenditure: United States, 1993

StateAll TypesAmbulatory Care2Hospital CareHome Health ServicesNursing Home
United States9.435.5811.445.9011.32
Alabama4.603.785.024.065.02
Alaska8.236.328.845.509.00
Arizona7.435.288.855.068.85
Arkansas6.985.197.755.677.77
California8.706.6310.046.2610.04
Colorado8.415.759.595.879.59
Connecticut7.146.017.656.917.65
Delaware8.595.6310.066.8110.00
District of Columbia5.864.226.375.076.33
Florida9.107.7010.237.6310.23
Georgia6.124.057.224.527.22
Hawaii8.206.859.016.679.00
Idaho6.435.436.864.766.84
Illinois6.273.007.714.637.71
Indiana7.063.258.385.178.38
Iowa5.192.606.133.856.13
Kansas7.145.158.055.148.05
Kentucky6.874.068.175.508.18
Louisiana7.124.288.515.268.54
Maine7.246.277.736.387.71
Maryland8.386.589.236.239.23
Massachusetts7.617.047.867.137.86
Michigan7.704.449.265.919.26
Minnesota6.864.927.684.987.68
Mississippi6.734.218.075.098.07
Missouri6.013.576.914.986.92
Montana14.557.0717.436.8517.45
Nebraska10.135.4611.945.0811.91
Nevada15.676.9221.578.3021.59
New Hampshire15.057.5618.607.7718.64
New Jersey15.267.4619.908.2819.90
New Mexico11.856.1814.865.9014.88
New York11.685.3714.516.4814.51
North Carolina8.854.9310.884.8310.88
North Dakota9.914.5111.874.8011.83
Ohio12.955.9316.036.6216.03
Oklahoma7.142.779.103.909.13
Oregon14.417.8517.866.8417.86
Pennsylvania12.185.3415.276.3715.27
Rhode Island13.096.6616.187.1316.18
South Carolina8.094.569.914.689.92
South Dakota10.815.3012.675.5012.63
Tennessee7.682.7410.364.3710.37
Texas11.915.2315.356.3215.35
Utah5.842.787.243.097.23
Vermont13.825.7817.497.0717.33
Virginia9.393.7211.935.1711.93
Washington11.924.7315.545.9815.54
West Virginia11.014.3013.845.9213.87
Wisconsin14.517.6917.227.2717.22
Wyoming38.775.3210.175.2210.20

SAFs are expressed as percentages of total Medicare expenditures, including amounts spent for persons with disabilities.

Includes physician and other professional services and medical durables.

No data from the Behavioral Risk Factor Surveillance System were available for Wyoming. The Wyoming SAFs were computed as the mean of the SAFs of its contiguous States: Montana, Idaho, Utah, Colorado, South Dakota, and Nebraska.

SOURCE: Zhang et al., San Francisco, California, 1999.

SAFs varied across States as a function of sociodemographic characteristics, smoking prevalence and history, and self-reported health status. Utah had the lowest total Medicare SAF (5.84 percent) and Nevada had the highest (15.67 percent). For each type of expenditure, there was considerable variation among the States. For ambulatory care, the total SAF for the United States was 5.58 percent. The highest ranking State, Oregon at 7.85 percent, had an SAF that was three times that of Iowa, at 2.6 percent. The State SAFs for hospital care ranged from 5.02 percent in Alabama to 21.57 percent in Nevada. The State SAFs for home health services were generally lower than for other expenditure categories, ranging from 3.09 percent in Utah to 8.3 percent in Nevada. SAFs for nursing home care ranged from 5.02 percent in Alabama to 21.59 percent in Nevada. Nevada had the highest State prevalence of smoking among adults, 30.3 percent, in 1992-93 (Centers for Disease Control and Prevention, 1996).

Estimated SAEs

Table 3 presents the estimated national and State Medicare SAEs by type of expenditure for calendar year 1993. The total estimated Medicare SAEs for the United States amounted to $14.2 billion. Of this total, $10.8 billion was for hospital care, $2.4 billion for ambulatory care (including amounts spent for physician and other professional services, and medical durables), $488 million for nursing home care, and $473 million for home health services.
Table 3

Medicare Smoking-Attributable Expenditures (SAEs) in Millions, by State and Type of Expenditure: United States, 1993

StateAll TypesAmbulatory Care2Hospital CareHome Health ServicesNursing Home
United States$14,182$2,445$10,776$473$488
Alabama1212681113
Alaska81700
Arizona1694311557
Arkansas99197542
California1,5084009934669
Colorado131249746
Connecticut1523696129
Delaware3262411
District of Columbia3562811
Florida1,1363676596149
Georgia21738158166
Hawaii41122811
Idaho2551811
Illinois402533251310
Indiana22123176814
Iowa7596410
Kansas95197122
Kentucky1472411264
Louisiana19428149161
Maine4493041
Maryland2255116455
Massachusetts359782372717
Michigan416703191512
Minnesota1482911037
Mississippi92156881
Missouri2073116565
Montana5774712
Nebraska76116311
Nevada115188945
New Hampshire7195732
New Jersey7381275861016
New Mexico67105322
New York1,3861801,1472435
North Carolina314492451010
North Dakota3743201
Ohio800996521534
Oklahoma1191110161
Oregon21937166313
Pennsylvania1,2251501,0112241
Rhode Island87116934
South Carolina125199754
South Dakota3953301
Tennessee27323218239
Texas1,0441248534324
Utah3742822
Vermont3332821
Virginia2572821757
Washington28133221621
West Virginia1221310522
Wisconsin34847276520
Wyoming1321001

Includes physician and other professional services and medical durables.

SOURCE: Zhang et al., San Francisco, California, 1999.

Differences in SAEs across States reflect differences in the size of the Medicare population, SAFs, and amounts spent by type of expenditure. California had the highest overall Medicare SAEs, $1.5 billion, followed by New York with $1.4 billion. Alaska had the lowest SAEs, $8 million. We applied the national interval estimates to each State to derive interval estimates of the State SAEs; we then aggregated these into estimated SAEs for each State. The 95-percent confidence interval ranges from $309 million to $28.0 billion. The relative error is 49.9 percent, which can be applied to the State point estimates.

Other SAEs

Table 4 shows the SAEs for Medicare, Medicaid, other public and private expenditures, and the total. In 1993, total SAEs for the Nation amounted to $72.7 billion. Of this total, SAEs for the Medicare program amounted to $14.2 billion, 19.5 percent of the total, while Medicaid SAEs amounted to $12.9 billion, 17.7 percent of the total. The remaining other public and private SAEs totaled $45.7 billion, 62.8 percent of the total. Other public programs include military and veterans' health programs, as well as State and local public programs. Private SAEs include private health insurance and out-of-pocket expenditures.
Table 4

Amount and Percent Distribution of Smoking-Attributable Expenditures (SAEs), by State and Source of Payment: United States, 1993

StateAmount in MillionsPercent


TotalMedicareMedicaid1Other Public and PrivateMedicareMedicaidOther Public and Private
United States$72,732$14,182$12,893$45,65719.517.762.8
Alabama80312110757515.013.471.6
Alaska1548241225.415.479.2
Arizona87716912258619.313.966.8
Arkansas604997842716.413.070.7
California8,7161,5081,7335,47517.319.962.8
Colorado93913115265613.916.169.9
Connecticut1,20015218286612.715.272.2
Delaware224322316914.410.275.5
District of Columbia316353624511.211.477.5
Florida4,6271,1365172,97424.611.264.3
Georgia1,7062172521,23712.714.872.5
Hawaii328414424312.413.474.1
Idaho179252512913.814.172.1
Illinois2,9684025612,00513.518.967.6
Indiana1,5602212551,08414.216.369.5
Iowa617757946312.212.975.0
Kansas634957246714.911.473.7
Kentucky1,02314720167514.419.666.0
Louisiana1,14719441753617.036.446.7
Maine338449619813.028.458.6
Maryland1,37922521294216.415.468.3
Massachusetts2,4573594061,69214.616.568.9
Michigan2,5804165331,63116.120.663.2
Minnesota1,21414818787912.215.472.4
Mississippi5499211134616.820.363.0
Missouri1,5022072071,08813.813.872.4
Montana205572812027.613.758.5
Nebraska396764327719.111.070.0
Nevada4181155025327.412.060.5
New Hampshire348719518220.527.252.3
New Jersey2,5837385451,30028.621.150.3
New Mexico365674825018.313.268.5
New York6,6481,3861,8513,41120.927.851.3
North Carolina1,6693142061,14918.812.368.8
North Dakota180371912420.610.668.9
Ohio3,3708005971,97323.717.758.6
Oklahoma6941198049517.211.671.3
Oregon7262198941830.212.357.6
Pennsylvania4,0081,2256062,17730.615.154.3
Rhode Island348879716425.027.847.1
South Carolina76812514250116.218.565.2
South Dakota174392111422.611.965.5
Tennessee1,38927330081619.621.658.8
Texas4,8221,0446543,12421.713.664.8
Utah209373413817.416.366.0
Vermont14633298423.019.957.5
Virginia1,34125716392119.212.168.7
Washington1,33328123781521.117.861.1
West Virginia49312211925224.724.251.1
Wisconsin1,37634819883025.314.460.3
Wyoming8013115616.414.470.0

Excludes amounts spent for people under age 19, psychiatric hospital care, and mental retardation nursing homes.

SOURCE: (Miller et al., 1998a,b); Zhang et al., San Francisco, California, 1999.

There is considerable variation among the States in the source of payment for SAEs, as shown in Table 4. Medicare SAEs in Alaska comprise only 5.4 percent of the total, while SAEs for Medicaid are 15.4 percent of the total, leaving almost four-fifths of the total, 79.2 percent, paid by other public and private sources. Louisiana, with its relatively high proportion of the total SAEs paid by Medicaid, 36.4 percent, leaves 17.0 percent paid by Medicare and less than one-half (46.7 percent) paid by other public and private programs. The 1993 SAFs and SAEs for the Nation are shown in Table 5 by source of payment. The SAF for total medical expenditures was 11.83 percent, but it varied by source of payment. The Medicare SAF was the lowest, at 9.43 percent, followed by Medicaid, at 12.14 percent, and the implicit SAF for other public and private sources, at 12.75 percent.
Table 5

Smoking-Attributable Fractions and Expenditures, by Source of Payment: United States, 1993 and 1997

Source of Payment1993
Total Medical Expenditures in MillionsSmoking-Attributable FractionSmoking-Attributable Expenditures in Millions
19931997
Total$614,56111.83$72,732$89,169
Medicare150,3739.4314,18220,479
Medicaid106,15612.1412,89316,954
Other Public and Private358,03212.7545,65751,736

SOURCES: (Miller et al., 1998a, b; Levit et al., 1998); Zhang et al., San Francisco, California, 1999.

Estimates of SAEs were updated to 1997 based on the increases in total personal health care, Medicare, and Medicaid expenditures (Levit et al., 1998). Total expenditures are projected to $89.2 billion in 1997, with Medicare increasing to $20.5 billion, Medicaid to $17.0 billion, and other public and private sources to $51.7 billion. The proportions of care paid by Medicare and Medicaid are projected to increase slightly from 1993 to 1997, from 19.5 percent to 23.0 percent for Medicare and from 17.7 percent to 19.0 percent for Medicaid, while the proportion of care paid by other sources is projected to decrease slightly (from 62.8 to 58.0 percent).

Conclusions

This study presents State-level estimates of Medicare expenditures attributable to smoking and compares them with SAEs by other payers. The SAF for Medicare is the lowest of the three payer groups for several reasons. Prescription drugs are not covered by Medicare but were found to have a relatively high SAF in previous work. Similarly, nursing homes, which were found to have the highest SAF for total medical expenditures, are covered under Medicare only in limited circumstances. Furthermore, the sickest smokers may die before they are eligible for Medicare, and hence their costs are included in other payer groups. It is for this reason that smoking prevalence for older people in the Medicare program is lower than it is for younger adults. The SAFs and SAEs reported here clearly show that cigarette smoking accounts for a substantial portion of annual State and national medical expenditures. There is considerable variation among the States in the proportions of Medicare, Medicaid, and other public and private medical payments attributable to smoking. The range in SAEs across States is attributable to differences in smoking prevalence, health status, and other socioeconomic variables used in the model as well as in the magnitude and patterns of medical expenditures in each State.

Technical Note

This Technical Note contains a detailed description of the estimation of the national model. Table A lists the variables included. The national model is based on an analysis of the NMES sample age 65 or over. Descriptive statistics for this sample are presented in Table B.
Table A

Variable Names and Definitions

VariableDefinition
LastageAge
BlackBlack
HispaothHispanic or Other Race
MidwestMiddle West
NrtheastNortheast
SouthSouth
MisseducMissing Education Information
HsgradHigh School Graduate
CollsomeSome College
CollgradCollege Graduate
LowincLow Income
MidincMiddle Income
HighincHigh Income
SepnvrrSeparated, Divorced, or Never Married
WidowedWidowed
McaidfxMedicaid Insured
PrivxPrivate Insured
InsurothOther Insurance
DisbedDisability Days
DiscdBed Days
CurrsmokCurrent Smoker
MissformFormer Smoker or Missing Smoking Information
PrevstarPropensity of Smoking-Related Disease
HlthstarPropensity of Poor Health Status
IMRInverse Mill's Ratio

SOURCE: Zhang et al., San Francisco, California, 1999.

Table B

Descriptive Statistics of National Medical Expenditure Survey Sample of Persons Age 65 or Over, by Sex: United States, 1993

VariableMalesFemales


MeanStandard DeviationMeanStandard Deviation
Lastage73.416.4174.006.82
Black0.110.310.130.33
Hispaoth0.050.220.050.21
Midwest0.260.440.260.44
Nrtheast0.190.390.200.40
South0.370.480.370.48
Misseduc0.020.140.020.12
Hsgrad0.280.450.300.46
Collsome0.110.310.110.32
Collgrad0.120.320.080.27
Lowinc0.170.380.210.41
Midinc0.360.480.300.46
Highinc0.350.480.250.43
Sepnvrr0.080.270.120.32
Widowed0.140.340.480.50
Mcaidfx0.050.200.120.32
Privx0.800.390.770.41
Insuroth0.010.070.010.08
Disbed6.7931.6611.2939.82
Discd12.5035.4416.7941.67
Overwght0.170.370.220.42
Sevwght0.060.240.090.28
Miswght0.040.210.050.23
Msblt0.050.220.060.23
Sbltrare0.230.420.220.41
Sbltsome0.180.380.170.37
Prevstar-0.010.84-0.180.83
Hlthstar1.491.051.601.07
IMR0.180.090.200.11

NOTE: The sample included 1,997 males and 2,970 females.

SOURCE: Zhang et al., San Francisco, California, 1999.

In order to address the issue of sample bias in the national model, we made the standard Heckman-Lee adjustments (Heckman, 1979; Lee, 1976). We estimated a probit equation predicting the propensity for supplemental survey participation. We incorporated the selection-bias correction term (inverse Mill's ratios) into the morbidity equations and into the ambulatory expenditure equations of the models. Table C presents the probit results for the propensity-to-participate equations, by sex. Note that the results presented in this article are for the models that incorporate sample-bias corrections. We explored the sensitivity of the results to the omission of consideration about sample-bias correction. The results with and without the sample-bias correction were similar.
Table C

Probit Model of Sample Participation, by Sex: United States, 1993

VariableMalesFemales


EstimateStandard ErrorEstimateStandard Error
Constant**1.860.47**3.180.35
Lastage**-0.010.01**-0.030.00
Black-0.010.14-0.160.11
Hispaoth0.150.19-0.040.15
Midwest-0.010.13-0.040.10
Nrtheast-0.180.12-0.230.10
South0.020.120.000.09
Misseduc**-0.460.20**-0.690.16
Hsgrad-0.080.090.050.07
Collsome0.180.150.100.11
Collgrad*0.270.160.000.12
Lowinc0.090.12-0.030.09
Midinc**0.410.12-0.120.09
Highinc**0.330.13-0.020.10
Sepnvrr0.020.130.180.12
Widowed*-0.200.10-0.060.07
Mcaidfx0.220.19**0.350.12
Privx**0.220.10**0.310.09
Insuroth0.320.55**-0.670.29
Disbed**0.000.00**0.000.00
Discd0.000.000.000.00
IMR**1.540.47**1.000.43

Significant at the 0.10 level.

Significant at the 0.05 level.

SOURCE: Zhang et al., San Francisco, California, 1999.

The morbidity portions of the model estimate the effect of smoking history on previous disease and the effect of smoking history and the propensity for previous disease on self-reported poor health status. The propensity to have a smoking-related disease as a function of smoking history was specified, controlling for sociodemographic, economic variables, other risk factors, and an inverse Mill's ratio. We estimated a probit model of smoking-related disease propensity (Table D). Most importantly, for both sexes, current and former smoking status (and those missing smoking information) was significantly related to an increase in the likelihood of a smoking-related disease.
Table D

Probit Model of Smoking-Related Diseases, by Sex: United States, 1993

VariableMalesFemales


EstimateStandard ErrorEstimateStandard Error
Constant**-2.090.38**-2.450.36
Currsmok**0.190.09*0.140.07
Missform**0.190.07**0.200.06
Lastage**0.020.01**0.030.01
Black**-0.450.11**-0.220.09
Hispaoth*-0.260.13**-0.260.12
Midwest-0.060.09-0.110.07
Nrtheast*-0.160.10**-0.200.08
South0.110.090.020.07
Misseduc-0.330.23**-0.670.26
Hsgrad0.080.070.010.06
Collsome0.110.10*0.140.08
Collgrad0.070.11**-0.200.09
Sepnvrr-0.010.10**0.180.08
Widowed*-0.180.090.080.05
Overwght*0.130.080.090.06
Sevwght*-0.200.120.120.09
Miswght-0.060.150.090.11
Msblt*-0.250.14-0.140.11
Sbltrare0.040.07-0.020.06
Sbltsome**-0.170.080.010.07
IMR**1.540.47**1.000.43

Significant at the 0.10 level.

Significant at the 0.05 level.

SOURCE: Zhang et al., San Francisco, California, 1999.

Poor health is a four-category, self-reported health-status measure: excellent, good, fair, and poor. We used an ordered probit model (McKelvey and Zavoina, 1975) and estimated the propensity for poor health as a function of the participant's expected propensity to previously have had a smoking-related disease, conditional on whether they did or did not have any smoking-related disease, an individual's smoking history, and the control variables previously discussed. Table E presents the point estimates for this poor health propensity equation. In both sex groups, both current-smoker status and a higher propensity to have had a previous smoking-related disease increase the propensity for poor health status. For males, current smoker status reduces the variance in the propensity measure. Although being a male former smoker increased the poor health propensity, being a female former smoker had no effect on the health propensity.
Table E

Ordered Probit Model of Poor Health, by Sex: United States, 1993

VariableMalesFemales


EstimateStandard ErrorEstimateStandard Error
Constant**1.010.32**1.840.30
Currsmok**0.200.08**0.160.06
Missform*0.120.06-0.020.05
Lastage0.000.00-0.010.00
Black**0.300.080.070.07
Hispaoth0.020.110.070.09
Midwest**0.160.08-0.070.06
Nrtheast*0.160.08**-0.190.07
South**0.220.07**0.200.06
Misseduc**-0.550.16**-0.690.19
Hsgrad**-0.210.06**-0.280.05
Collsome**-0.190.09**-0.420.07
Collgrad**-0.390.09**-0.540.08
Sepnvrr*-0.170.09**0.190.07
Widowed**-0.280.08**-0.210.05
Overwght-0.010.07*0.080.05
Sevwght**0.320.11**0.230.08
Miswght-0.050.110.070.09
Msblt**0.210.10**0.230.10
Sbltrare**0.130.06**0.240.05
Sbltsome*0.120.070.040.06
Prevstar**0.530.04**0.470.03
IMR**2.480.37**2.070.35
Variance
Currsmok*-0.120.07-0.060.05
Missform-0.040.050.040.04
Threshold
MU(1)**1.53480.06761**1.60520.04378
MU(2)**2.8530.11768**2.92040.06126

Significant at the 0.10 level.

Significant at the 0.05 level.

SOURCE: Zhang et al., San Francisco, California, 1999.

Two Medicare expenditure equations were estimated for each of three types of medical expenditures: ambulatory, hospital, and home health care. The first equation is a probit equation estimating the propensity for positive Medicare expenditures. The second is a log expenditure equation estimating the logarithm of the magnitude of expenditures, given expenditures were positive. Table F presents point estimates for the ambulatory, hospital, and home health care propensities for positive expenditures, and Table G presents point estimates for the logarithm of positive expenditure levels for these same types of medical expenditures.
Table F

Estimates of Probit Model of Having Positive Expenditures, by Type of Expenditure and Sex: United States, 1993

VariableAmbulatory CareHospital CareHome Health Care



MalesFemalesMalesFemalesMalesFemales
Constant-0.41-0.13**-1.84**-2.58**-1.96**-1.30
Lastage0.010.010.01**0.01**0.01**0.01
Black**-0.260.12-0.04-0.05-0.19-0.04
Hispaoth*-0.28-0.07-0.01*-0.260.020.00
Midwest-0.15-0.02-0.040.020.02*-0.14
Nrtheast-0.160.120.04-0.07*-0.18**-0.22
South-0.12-0.07-0.06-0.08-0.06**-0.24
Lowinc*0.22-0.080.01-0.070.080.04
Midinc0.210.170.11-0.060.130.08
Highinc**0.400.09-0.010.030.170.12
Misseduc-0.36-0.130.09-0.210.30**-0.56
Hsgrad**0.200.04*0.16*0.120.080.06
Collsome**0.29**0.32*0.210.12**0.23**0.21
Collgrad**0.560.20**0.32-0.08**0.31**0.25
Sepnvrr*-0.210.030.020.08*0.190.09
Widowed**-0.27*0.16-0.15**0.130.12**0.24
Overwght0.16-0.04**-0.18-0.01-0.06-0.08
Sevwght0.270.11**-0.290.03**0.26-0.07
Miswght-0.18-0.04-0.13-0.10-0.010.08
Msblt*-0.28**-0.45-0.04-0.18**-0.29**-0.23
Sbltrare-0.06**-0.39*0.16**-0.18-0.02-0.06
Sbltsome0.06**-0.220.020.06-0.010.06
Mcaidfx0.30**0.400.18**0.220.10**0.25
Privx**0.28**0.460.040.12**0.200.03
Hlthstar**0.29**0.30**0.28**0.37**0.30**0.24
Currsmok-0.06**-0.25-0.15-0.090.03-0.11
Missform**0.190.13-0.03**0.160.10**0.21
IMR11.10-1.04

Significant at the 0.10 level.

Significant at the 0.05 level.

IMR (inverse Mill's ratio) only included in ambulatory model.

SOURCE: Zhang et al., San Francisco, California, 1999.

Table G

Estimates of Regression Model of Logarithm of Positive Expenditures, by Type of Expenditure and Sex

VariableAmbulatory CareHospital CareHome Health Care



MalesFemalesMalesFemalesMalesFemales
Constant**5.62**6.21**8.71**7.66**3.61**2.43
Lastage**-0.03*-0.010.000.01**0.02**0.03
Black-0.090.010.06**0.33-0.03-0.18
Hispaoth10.09-0.130.27**-0.57
Midwest**-0.23**-0.36*-0.31-0.05-0.15-0.01
Nrtheast**-0.36**-0.28-0.09-0.04-0.12-0.14
South**-0.30**-0.47-0.21**-0.29*-0.24-0.18
Lowinc0.09-0.09-0.150.080.270.13
Midinc**0.78-0.03-0.220.130.09*0.19
Highinc**0.720.07-0.22-0.10-0.030.20
Misseduc2-0.30*-0.48
Hsgrad0.04**0.16*0.25**0.230.040.01
Collsome**0.31**0.190.26-0.190.110.07
Collgrad**0.78**0.22*0.31-0.130.010.15
Sepnvrr**0.27**0.25-0.090.08-0.140.14
Widowed**-0.34*0.110.060.160.120.14
Overwght-0.11*0.12-0.09-0.06*-0.33-0.03
Sevwght-0.03-0.09**-0.73*-0.29-0.140.04
Miswght-0.150.100.03-0.27-0.10-0.03
Msblt3-0.17**-0.260.31-0.08
Sbltrare-0.14**-0.23-0.13-0.01-0.040.11
Sbltsome**-0.19-0.090.04-0.11-0.18-0.04
Mcaidfx**0.43**0.420.16-0.020.40**0.96
Privx**0.50**0.32*0.260.060.010.02
Hlthstar**0.35**0.32**0.18**0.26**0.21**0.21
Currsmok-0.07**-0.260.050.00-0.050.13
Missform0.07**0.23**-0.270.02-0.03*0.17
IMR4**4.620.22
Sigma**1.28**1.29**1.09**1.07**1.43**1.39
Variance
Currsmok*0.18**0.17-0.12**0.45-0.22-0.13
Missform**0.21-0.050.050.14-0.16**0.23

Significant at the 0.10 level.

Significant at the 0.05 level.

Too few observations, combined with black persons in the hospital model.

Too few observations, combined with less than high school in hospital and home health model.

Too few observations, combined with seatbelt always in hospital model.

IMR (inverse Mill's ratio) included only in ambulatory model.

SOURCE: Zhang et al., San Francisco, California, 1999.

The propensity-for-poor-health variable captures the health and disease effect on expenditures caused by smoking. The smoking-history variables, controlling for poor health, capture an associative effect of smoking on expenditures. This associative effect is the resolution of some health effects not captured by the propensity for poor health and some demand effects associated with smoking. An example of a health effect not captured by the poor-health-status model is illustrated by pregnancy. Pregnant women do not usually think of themselves as having poorer health status. Pregnancy has been found to increase the likelihood or magnitude of positive expenditures (Adams, Solanki, and Miller, 1997). Consequently, the poor-health measure misses increments to expenditure attributable to the effect of smoking on pregnancy. An example of a demand effect is as follows: If individuals with a smoking history do not look after their health as regularly as individuals without a smoking history, the demand of the former group for medical care and medical expenditures is lower. The direct effect of smoking history, controlling for poor health, reflects both of these behaviors and others as well. The causal effect of smoking on expenditures, reflected by the coefficient on the health propensity in both the likelihood and the magnitude of expenditure equations is always positive and statistically significant. This is true for both the propensity and magnitude of every type of medical expenditure covered by Medicare. The associative effects vary by type of medical expenditure and by sex. For example, former male smokers have a higher likelihood of positive ambulatory expenditures, and former female smokers have a higher likelihood of positive hospital and home health care expenditures. Former male smokers have a lower magnitude of hospital expenditures, and former female smokers have a lower magnitude of home health care expenditures. The direct-smoking-history variables also influence the variance in the magnitude of medical expenditures. When the effect is significant, it always increases the variance in expenditures. The estimated effects include the following: Every male history of smoking increases the variance in male ambulatory expenditures; for females, being a current smoker increases the variance in ambulatory and hospital expenditures; being a former smoker increases the variance in home health expenditures.
  9 in total

1.  State estimates of Medicaid expenditures attributable to cigarette smoking, fiscal year 1993.

Authors:  L S Miller; X Zhang; T Novotny; D P Rice; W Max
Journal:  Public Health Rep       Date:  1998 Mar-Apr       Impact factor: 2.792

2.  State estimates of total medical expenditures attributable to cigarette smoking, 1993.

Authors:  L S Miller; X Zhang; D P Rice; W Max
Journal:  Public Health Rep       Date:  1998 Sep-Oct       Impact factor: 2.792

3.  National health expenditures in 1997: more slow growth.

Authors:  K Levit; C Cowan; B Braden; J Stiller; A Sensenig; H Lazenby
Journal:  Health Aff (Millwood)       Date:  1998 Nov-Dec       Impact factor: 6.301

4.  The economic costs of the health effects of smoking, 1984.

Authors:  D P Rice; T A Hodgson; P Sinsheimer; W Browner; A N Kopstein
Journal:  Milbank Q       Date:  1986       Impact factor: 4.911

5.  The economic costs of cigarette smoking.

Authors:  J L Hedrick
Journal:  HSMHA Health Rep       Date:  1971-02

6.  State health expenditure accounts: building blocks for state health spending analysis.

Authors:  K R Levit; H C Lazenby; C A Cowan; D K Won; J M Stiller; L Sivarajan; M Stewart
Journal:  Health Care Financ Rev       Date:  1995

7.  Medical-care expenditures attributable to cigarette smoking--United States, 1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1994-07-08       Impact factor: 17.586

8.  Economic issues in prevention.

Authors:  M M Kristein
Journal:  Prev Med       Date:  1977-06       Impact factor: 4.018

9.  Smoking and alcohol abuse: a comparison of their economic consequences.

Authors:  B R Luce; S O Schweitzer
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

  9 in total
  11 in total

1.  Evaluating the tobacco settlement damage awards: too much or not enough?

Authors:  Maribeth Coller; Glenn W Harrison; Melayne Morgan McInnes
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

2.  Optimal commodity taxation with moral hazard and unobservable outcomes.

Authors:  Gerard Russo
Journal:  Int J Health Care Finance Econ       Date:  2003-03

3.  Health care costs among smokers, former smokers, and never smokers in an HMO.

Authors:  Paul A Fishman; Zeba M Khan; Ella E Thompson; Susan J Curry
Journal:  Health Serv Res       Date:  2003-04       Impact factor: 3.402

4.  Estimates of state-level health-care expenditures associated with disability.

Authors:  Wayne L Anderson; Brian S Armour; Eric A Finkelstein; Joshua M Wiener
Journal:  Public Health Rep       Date:  2010 Jan-Feb       Impact factor: 2.792

5.  Smoking attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan.

Authors:  M C Yang; C Y Fann; C P Wen; T Y Cheng
Journal:  Tob Control       Date:  2005-06       Impact factor: 7.552

6.  The disproportionate cost of smoking for African Americans in California.

Authors:  Wendy Max; Hai-Yen Sung; Lue-Yen Tucker; Brad Stark
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

7.  Impact of cigarette smoking on utilization of nursing home services.

Authors:  Kenneth E Warner; Ryan J McCammon; Brant E Fries; Kenneth M Langa
Journal:  Nicotine Tob Res       Date:  2013-06-26       Impact factor: 4.244

Review 8.  Tobacco cessation in primary care: maximizing intervention strategies.

Authors:  John D Anczak; Robert A Nogler
Journal:  Clin Med Res       Date:  2003-07

9.  The economic burden of smoking in California.

Authors:  W Max; D P Rice; H-Y Sung; X Zhang; L Miller
Journal:  Tob Control       Date:  2004-09       Impact factor: 7.552

Review 10.  A review of economic evaluations of tobacco control programs.

Authors:  Jennifer W Kahende; Brett R Loomis; Bishwa Adhikari; Latisha Marshall
Journal:  Int J Environ Res Public Health       Date:  2008-12-28       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.